Written Confirmations for export to EEA and Northern Ireland of Active Substances manufactured in Great Britain
Published 1 September 2020
New rules for January 2021
The UK has left the EU, and the transition period after Brexit comes to an end this year.
This page tells you what you’ll need to do from 1 January 2021. It will be updated if anything changes.
For current information, read: Good manufacturing practice and good distribution practice
You can also read about the transition period.
1. Purpose of the Written Confirmation
A Written Confirmation confirms that, for a third country exporting Active Substances to the EEA:
- the standards of Good Manufacturing Practice (GMP) are equivalent to those in the EU/EEA
- the manufacturing plant is subject to regular inspections (which may be both announced and unannounced)
- significant non-compliance events would be communicated to the EEA without delay
A template for the Written Confirmation can be found on the European Commission website.
The requirement for the Written Confirmation is stated in Article 46b(2)(b) of Directive 2001/83/EC.
2. ‘Third Country’ status for Great Britain (England, Wales and Scotland) manufacturers of Active Substances
From 1 January 2021, Great Britain will be recognised as a Third Country for the export of Active Substances for human use to the EEA. Active Substance manufacturers in Northern Ireland will continue to be recognised by the EEA.
A Written Confirmation will then be required for each shipment of Active Substance manufactured in Great Britain that is exported to the EEA and Northern Ireland.
3. Generation of Written Confirmations for Active Substances manufactures in the UK
You will not need to provide any information to the MHRA to allow the Written Confirmation to be generated. All the information required for the Written Confirmations is available within MHRA systems.
Written Confirmations will be generated for Active Substance manufacturers in Great Britain whether they intend to export Active Substances or not.
3.1. Biological products
Manufacture of biological active substance is considered to be partial manufacture of the biological medicinal product. These activities are recorded in section 1.3 of the UK Manufacturing Authorisation (MIA) and the associated GMP certificate issued following a satisfactory inspection “(EU Interpretation of the Union Format for Manufacturer/Importer Authorisation)”.
If you hold an MIA that includes manufacture of biological active substance, separate registration as an active substance manufacturer is not required. No written confirmation will be issued, as this is already confirmed by the MHRA GMP certificate.
4. Obtaining Written Confirmations for Active Substances manufactured in other third countries
There will be no change to the requirements for obtaining Written Confirmations for importation of Active Substances from other ‘Third Countries’. You will still need to obtain the Written Confirmations from the issuing authority in that country.
A Written Confirmation will not be required for the supply of Active Substance manufactured in Northern Ireland to Great Britain.
5. Requirements for distributors of Active Substances
If you are a Distributor of Active Substances that you did not manufacture, Written Confirmations will not be generated for your activities. If a Written Confirmation is required for export activities, it can be obtained from the appropriate issuing authority, or directly from the manufacturer.
6. Validity period of a Written Confirmation
A Written Confirmation is valid for a the same period as the corresponding GMP certificate. Where required the MHRA will offer an assessment to reissue GMP certificates of Active Substance manufacturing sites in Great Britain, prior to 1 January 2021, to allow generation of Written Confirmations with an appropriate validity period.
- Provision of Written Confirmations for each shipment of Active Substances exported to the EEA and Northern Ireland
A ‘Questions and Answers’ document on the EU expectations relating to Written Confirmations is available on the European Commission website. This document identifies how the Written Confirmation should be provided to the customer within the EEA.
8. Companies with confidential GMP certificates
If your company has a confidential GMP certificate due to the nature of the Active Substances manufactured, the Written Confirmation will not be published on the MHRA website. The Written Confirmation will be sent to the contact named on your Active Substance registration.
9. Requirement for both a GMP certificate and a Written Confirmation
Although similar information is contained in a GMP certificate and a Written Confirmation, both documents serve different purposes:
- UK law requires a GMP certificate to be issued after an inspection
- EU regulations require a Written Confirmation for any import of Active Substances into the EEA by a Third Country
If you export Active Substances made in Great Britain to the EEA or Northern Ireland, you are therefore required to have a valid GMP certificate and a valid Written Confirmation.
10. Ongoing requirement for Written Confirmations
The need for Written Confirmations is expected to be an interim position. At a suitable point after 1 January 2021, an application will be made to recognise Great Britain’s GMP standards for the manufacture of Active Substances in Great Britain as equivalent to those in the EU.
Once a country has been accepted as having equivalent GMP standards, they are added to a ‘White List’ and Written Confirmations are then no longer required.